Psychemedics Corporation (PMD)

2,5500 -0,0400 (-1,54%) Alla chiusura: 04:00PM EDT

Psychemedics Corporation

5220 Spring Valley Road
Suite 230
Dallas, TX 75254
United States
800 527 7424
https://www.psychemedics.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 116

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Brian Hullinger	President, CEO & Director	361,37k	N/D	1968
Ms. Daniella Mehalik	Vice President of Finance	126,41k	N/D	1990
Ms. Shannon Shoemaker	Chief Revenue Officer	187,82k	N/D	N/D
Dr. Werner A. Baumgartner Ph.D.	Founder	N/D	N/D	N/D
Ms. Annette Baumgartner	Founder	N/D	N/D	N/D
Mr. Michael Weisenhoff	Principal Financial & Accounting Manager	N/D	N/D	1990
Mr. Patrick J. Kinney Jr.	Secretary	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Governance aziendale

L'ISS Governance QualityScore di Psychemedics Corporation al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.